CME Group Inc. (NASDAQ:CME) Stock Position Lowered by CHICAGO TRUST Co NA

CHICAGO TRUST Co NA lowered its position in shares of CME Group Inc. (NASDAQ:CME) by 3.9% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 2,430 shares of the financial services provider’s stock after selling 98 shares during the period. CHICAGO TRUST Co NA’s holdings in CME Group were worth $645,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the company. New Age Alpha Advisors LLC boosted its stake in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 43 shares in the last quarter. Knuff & Co LLC purchased a new stake in shares of CME Group during the fourth quarter valued at $33,000. Banque Transatlantique SA acquired a new position in shares of CME Group in the 4th quarter valued at $35,000. Whipplewood Advisors LLC purchased a new position in CME Group in the 4th quarter worth about $37,000. Finally, United Community Bank purchased a new position in CME Group in the 4th quarter worth about $37,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Larry G. Gerdes sold 2,000 shares of CME Group stock in a transaction dated Thursday, April 24th. The stock was sold at an average price of $264.10, for a total value of $528,200.00. Following the transaction, the director now directly owns 38,651 shares in the company, valued at approximately $10,207,729.10. The trade was a 4.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Daniel G. Kaye sold 500 shares of the stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the sale, the director now owns 3,668 shares of the company’s stock, valued at approximately $1,035,916.56. The trade was a 12.00% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 22,900 shares of company stock worth $6,147,935. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

NASDAQ CME opened at $268.35 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $96.70 billion, a PE ratio of 27.75, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $290.79. The company has a 50 day moving average price of $271.81 and a two-hundred day moving average price of $253.55.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. CME Group’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.50 EPS. As a group, equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.86%. The ex-dividend date is Monday, June 9th. CME Group’s payout ratio is 50.30%.

Analyst Ratings Changes

CME has been the subject of several recent analyst reports. Bank of America raised their target price on shares of CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a report on Wednesday, April 2nd. UBS Group lifted their price objective on shares of CME Group from $290.00 to $305.00 and gave the stock a “buy” rating in a research report on Friday, April 25th. Barclays increased their target price on CME Group from $279.00 to $283.00 and gave the company an “equal weight” rating in a report on Wednesday, April 23rd. Raymond James raised CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 target price for the company in a research report on Monday, March 10th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $258.20.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.